BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cates J, Lucero-Obusan C, Dahl RM, Schirmer P, Garg S, Oda G, Hall AJ, Langley G, Havers FP, Holodniy M, Cardemil CV. Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1528-34. [PMID: 33090987 DOI: 10.15585/mmwr.mm6942e3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, Morris J, Crystal C, Igbinadolor A, Huhn G, Cardona J, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, Durante M, Oakley G, Schade AE, Holzer TR, Ebert PJ, Higgs RE, Kallewaard NL, Sabo J, Patel DR, Dabora MC, Klekotka P, Shen L, Skovronsky DM; BLAZE-1 Investigators. Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19. N Engl J Med 2021. [PMID: 34260849 DOI: 10.1056/NEJMoa2102685] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
2 Saha BK, Chong WH, Austin A, Kathuria R, Datar P, Shkolnik B, Beegle S, Chopra A. Pleural abnormalities in COVID-19: a narrative review. J Thorac Dis 2021;13:4484-99. [PMID: 34422375 DOI: 10.21037/jtd-21-542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Astore C, Zhou H, Jacob J, Skolnick J. Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications. Sci Rep 2021;11:20864. [PMID: 34675303 DOI: 10.1038/s41598-021-00368-6] [Reference Citation Analysis]
4 Long B, Carius BM, Liang SY, Chavez S, Brady WJ, Koyfman A, Gottlieb M. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation. The American Journal of Emergency Medicine 2022. [DOI: 10.1016/j.ajem.2022.01.028] [Reference Citation Analysis]
5 Chuang Y, Tsai H, Liu S, Wu M, Liu P. COVID-19 in Veterans: A Narrative Review. RMHP 2022;Volume 15:805-15. [DOI: 10.2147/rmhp.s354814] [Reference Citation Analysis]
6 Meites E, Bajema KL, Kambhampati A, Prill M, Marconi VC, Brown ST, Rodriguez-Barradas MC, Beenhouwer DO, Holodniy M, Lucero-Obusan C, Cardemil C, Cates J, Surie D. Adapting the Surveillance Platform for Enteric and Respiratory Infectious Organisms at United States Veterans Affairs Medical Centers (SUPERNOVA) for COVID-19 Among Hospitalized Adults: Surveillance Protocol. Front Public Health 2021;9:739076. [PMID: 34778173 DOI: 10.3389/fpubh.2021.739076] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Putot A, Bouiller K, Laborde C, Gilis M, Févre A, Hacquin A, Manckoundia P, Hoefler F, Bermejo M, Mendes A, Serratrice C, Prendki V, Sanchez S. Association between Early Antibiotic Therapy and In-Hospital Mortality among Older Patients with SARS-CoV-2 Pneumonia. J Gerontol A Biol Sci Med Sci 2021:glab209. [PMID: 34272847 DOI: 10.1093/gerona/glab209] [Reference Citation Analysis]
8 Jabr Alwazzeh M, Mohammed Telmesani L, Saud AlEnazi A, Abdulwahab Buohliqah L, Talal Halawani R, Jatoi NA, Subbarayalu AV, Abdulaziz Almuhanna F. Seasonal influenza vaccination coverage and its association with COVID-19 in Saudi Arabia. Inform Med Unlocked 2021;27:100809. [PMID: 34869828 DOI: 10.1016/j.imu.2021.100809] [Reference Citation Analysis]
9 Moore KS. The Impact of COVID-19 on the Latinx Population: A Scoping Literature Review. Public Health Nurs 2021;38:789-800. [PMID: 33876506 DOI: 10.1111/phn.12912] [Reference Citation Analysis]
10 Taniguchi Y, Kuno T, Komiyama J, Adomi M, Suzuki T, Abe T, Ishimaru M, Miyawaki A, Saito M, Ohbe H, Miyamoto Y, Imai S, Kamio T, Tamiya N, Iwagami M. Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017-2020: a multicenter, retrospective cohort study in Japan. Lancet Reg Health West Pac 2022;20:100365. [PMID: 35005672 DOI: 10.1016/j.lanwpc.2021.100365] [Reference Citation Analysis]
11 Sarfaraz S, Shaikh Q, Saleem SG, Rahim A, Herekar FF, Junejo S, Hussain A. Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan. PLoS One 2021;16:e0251754. [PMID: 34043674 DOI: 10.1371/journal.pone.0251754] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Nezhadmoghadam F, Tamez-Peña J. Risk profiles for negative and positive COVID-19 hospitalized patients. Comput Biol Med 2021;136:104753. [PMID: 34411902 DOI: 10.1016/j.compbiomed.2021.104753] [Reference Citation Analysis]
13 Daly SR, Nguyen AV, Zhang Y, Feng D, Huang JH. The relationship between COVID-19 infection and intracranial hemorrhage: A systematic review. Brain Hemorrhages 2021;2:141-50. [PMID: 34786548 DOI: 10.1016/j.hest.2021.11.003] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Cueto-Manzano AM, Espinel-Bermúdez MC, Hernández-González SO, Rojas-Campos E, Nava-Zavala AH, Fuentes-Orozco C, Balderas-Peña LMA, González-Ojeda A, Cortes-Sanabria L, Mireles-Ramírez MA, Ramírez-Márquez JJ, Martínez-Gutiérrez PE, Ávila-Morán M, De-Dios-Pérez RI, Acosta-Ramírez C, Hernández-García HR. Risk factors for mortality of adult patients with COVID-19 hospitalised in an emerging country: a cohort study. BMJ Open 2021;11:e050321. [PMID: 34281931 DOI: 10.1136/bmjopen-2021-050321] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Hou C, Hu Y, Yang H, Chen W, Zeng Y, Ying Z, Hu Y, Sun Y, Qu Y, Gottfreðsson M, Valdimarsdóttir UA, Song H. COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank. BMC Med 2021;19:301. [PMID: 34781951 DOI: 10.1186/s12916-021-02177-0] [Reference Citation Analysis]
16 Drake TM, Riad AM, Fairfield CJ, Egan C, Knight SR, Pius R, Hardwick HE, Norman L, Shaw CA, McLean KA, Thompson AAR, Ho A, Swann OV, Sullivan M, Soares F, Holden KA, Merson L, Plotkin D, Sigfrid L, de Silva TI, Girvan M, Jackson C, Russell CD, Dunning J, Solomon T, Carson G, Olliaro P, Nguyen-Van-Tam JS, Turtle L, Docherty AB, Openshaw PJ, Baillie JK, Harrison EM, Semple MG; ISARIC4C investigators. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet 2021;398:223-37. [PMID: 34274064 DOI: 10.1016/S0140-6736(21)00799-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
17 Baghdadi JD, Coffey KC, Adediran T, Goodman KE, Pineles L, Magder LS, O'Hara LM, Pineles BL, Nadimpalli G, Morgan DJ, Harris AD. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients. Antimicrob Agents Chemother 2021;65:e0134121. [PMID: 34491806 DOI: 10.1128/AAC.01341-21] [Reference Citation Analysis]
18 Wu J, Ma Z, Raman A, Beckerman P, Dhillon P, Mukhi D, Palmer M, Chen HC, Cohen CR, Dunn T, Reilly J, Meyer N, Shahaty M, Arany Z, Haskó G, Laudanski K, Hung A, Susztak K. APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis. Immunity 2021;54:2632-2649.e6. [PMID: 34715018 DOI: 10.1016/j.immuni.2021.10.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Langford BJ, So M, Leung V, Raybardhan S, Lo J, Kan T, Leung F, Westwood D, Daneman N, MacFadden DR, Soucy JR. Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression. Clin Microbiol Infect 2021:S1198-743X(21)00636-4. [PMID: 34843962 DOI: 10.1016/j.cmi.2021.11.008] [Reference Citation Analysis]
20 Oi I, Ito I, Hirabayashi M, Endo K, Emura M, Kojima T, Tsukao H, Tomii K, Nakagawa A, Otsuka K, Akai M, Oi M, Sugita T, Fukui M, Inoue D, Hasegawa Y, Takahashi K, Yasui H, Fujita K, Ishida T, Ito A, Kita H, Kaji Y, Tsuchiya M, Tomioka H, Yamada T, Terada S, Nakaji H, Hamao N, Shirata M, Nishioka K, Yamazoe M, Shiraishi Y, Ogimoto T, Hosoya K, Ajimizu H, Shima H, Matsumoto H, Tanabe N, Hirai T. Pneumonia Caused by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Virus: A Multicenter Comparative Study. Open Forum Infect Dis 2021;8:ofab282. [PMID: 34291119 DOI: 10.1093/ofid/ofab282] [Reference Citation Analysis]
21 Montgomery MP, Hong K, Clarke KEN, Williams S, Fukunaga R, Fields VL, Park J, Schieber LZ, Kompaniyets L, Ray CM, Lambert LA, D'Inverno AS, Ray TK, Jeffers A, Mosites E. Hospitalizations for COVID-19 Among US People Experiencing Incarceration or Homelessness. JAMA Netw Open 2022;5:e2143407. [PMID: 35024835 DOI: 10.1001/jamanetworkopen.2021.43407] [Reference Citation Analysis]
22 Tezza F, Lorenzoni G, Azzolina D, Barbar S, Leone LAC, Gregori D. Predicting in-Hospital Mortality of Patients with COVID-19 Using Machine Learning Techniques. J Pers Med 2021;11:343. [PMID: 33923332 DOI: 10.3390/jpm11050343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
23 Ippolito M, Simone B, Filisina C, Catalanotto FR, Catalisano G, Marino C, Misseri G, Giarratano A, Cortegiani A. Bloodstream Infections in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Microorganisms 2021;9:2016. [PMID: 34683337 DOI: 10.3390/microorganisms9102016] [Reference Citation Analysis]
24 Luo J, Rosales M, Wei G, Stoddard GJ, Kwok AC, Jeyapalina S, Agarwal JP. Hospitalization, Mechanical Ventilation, and Case-Fatality Outcomes in US Veterans with COVID-19 Disease between years 2020-2021. Annals of Epidemiology 2022. [DOI: 10.1016/j.annepidem.2022.04.003] [Reference Citation Analysis]
25 Boutou AK, Georgopoulou A, Pitsiou G, Stanopoulos I, Kontakiotis T, Kioumis I. Changes in the respiratory function of COVID-19 survivors during follow-up: A novel respiratory disorder on the rise? Int J Clin Pract 2021;:e14301. [PMID: 33932073 DOI: 10.1111/ijcp.14301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Osman M, Klopfenstein T, Belfeki N, Gendrin V, Zayet S. A Comparative Systematic Review of COVID-19 and Influenza. Viruses 2021;13:452. [PMID: 33802155 DOI: 10.3390/v13030452] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Hedberg P, Karlsson Valik J, van der Werff S, Tanushi H, Requena Mendez A, Granath F, Bell M, Mårtensson J, Dyrdak R, Hertting O, Färnert A, Ternhag A, Naucler P. Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data. Thorax 2021:thoraxjnl-2021-216949. [PMID: 34226206 DOI: 10.1136/thoraxjnl-2021-216949] [Reference Citation Analysis]
28 Asukai Y, Briggs A, Garrison LP, Geisler BP, Neumann PJ, Ollendorf DA. Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic. Pharmacoeconomics 2021;39:1201-8. [PMID: 34557996 DOI: 10.1007/s40273-021-01088-5] [Reference Citation Analysis]
29 Shrestha SS, Kompaniyets L, Grosse SD, Harris AM, Baggs J, Sircar K, Gundlapalli AV. Estimation of Coronavirus Disease 2019 Hospitalization Costs From a Large Electronic Administrative Discharge Database, March 2020-July 2021. Open Forum Infect Dis 2021;8:ofab561. [PMID: 34938822 DOI: 10.1093/ofid/ofab561] [Reference Citation Analysis]
30 Belvitch P, Casanova N, Sun X, Camp SM, Sammani S, Brown ME, Mascarhenas J, Lynn H, Adyshev D, Siegler J, Desai A, Seyed-Saadat L, Rizzo A, Bime C, Shekhawat GS, Dravid VP, Reilly JP, Jones TK, Feng R, Letsiou E, Meyer NJ, Ellis N, Garcia JGN, Dudek SM. A cortactin CTTN coding SNP contributes to lung vascular permeability and inflammatory disease severity in African descent subjects. Transl Res 2022:S1931-5244(22)00022-6. [PMID: 35181549 DOI: 10.1016/j.trsl.2022.02.002] [Reference Citation Analysis]
31 Chong WH, Saha BK, Hu K, Chopra A. The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review. Heart Lung 2021;50:599-608. [PMID: 34087677 DOI: 10.1016/j.hrtlng.2021.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Blazoski CM, Baram M, Yang Q, Hirose H. Outcomes of extracorporeal membrane oxygenation in influenza versus COVID-19 during the first wave of COVID-19. J Card Surg 2021. [PMID: 34369601 DOI: 10.1111/jocs.15888] [Reference Citation Analysis]
33 Phillips MC, Sarff L, Banerjee J, Coffey C, Holtom P, Meurer S, Wald-Dickler N, Spellberg B. Effect of mortality from COVID-19 on inpatient outcomes. J Med Virol 2022;94:318-26. [PMID: 34516010 DOI: 10.1002/jmv.27332] [Reference Citation Analysis]
34 Terry PD, Heidel RE, Dhand R. Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease. Am J Respir Crit Care Med 2021;203:893-905. [PMID: 33493416 DOI: 10.1164/rccm.202008-3266OC] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
35 Emami A, Pezeshkian F, Javanmardi F, Akbari A, Asadi-Pooya AA. COVID-19 in Patients With a Past History of Chemical War Injury: A Cross-Sectional Study in Southern Iran. Disaster Med Public Health Prep 2021;:1-3. [PMID: 33938418 DOI: 10.1017/dmp.2021.137] [Reference Citation Analysis]
36 Hooper L, Abdelhamid A, Ajabnoor SM, Esio-bassey C, Brainard J, Brown TJ, Bunn D, Foster E, Hammer CC, Hanson S, Jimoh FO, Maimouni H, Sandhu M, Wang X, Winstanley L, Cross JL, Welch AA, Rees K, Philpott C. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis. Clinical Nutrition ESPEN 2022;47:96-105. [DOI: 10.1016/j.clnesp.2021.11.021] [Reference Citation Analysis]
37 Cheruku SR, Barina A, Kershaw CD, Goff K, Reisch J, Hynan LS, Ahmed F, Armaignac DL, Patel L, Belden KA, Kaufman M, Christie AB, Deo N, Bansal V, Boman K, Kumar VK, Walkey A, Kashyap R, Gajic O, Fox AA; Society of Critical Care Medicine Discovery Viral Infection, Respiratory Illness Universal Study VIRUS: COVID-19 Registry Investigator Group. Palliative care consultation and end-of-life outcomes in hospitalized COVID-19 patients. Resuscitation 2021;170:230-7. [PMID: 34920014 DOI: 10.1016/j.resuscitation.2021.12.011] [Reference Citation Analysis]
38 Davazdahemami B, Zolbanin HM, Delen D. An explanatory machine learning framework for studying pandemics: The case of COVID-19 emergency department readmissions. Decision Support Systems 2022. [DOI: 10.1016/j.dss.2022.113730] [Reference Citation Analysis]
39 Tanne JH. Covid 19: Patients have many more complications than flu patients, finds US study. BMJ. [DOI: 10.1136/bmj.m4106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Cardemil CV, Dahl R, Prill MM, Cates J, Brown S, Perea A, Marconi V, Bell L, Rodriguez-Barradas MC, Rivera-Dominguez G, Beenhouwer D, Poteshkina A, Holodniy M, Lucero-Obusan C, Balachandran N, Hall AJ, Kim L, Langley G. COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study. JMIR Public Health Surveill 2021;7:e24502. [PMID: 33338028 DOI: 10.2196/24502] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
41 Marcus JE, Sams VG, Barsoumian AE. Elevated secondary infection rates in patients with coronavirus disease 2019 (COVID-19) requiring extracorporeal membrane oxygenation. Infect Control Hosp Epidemiol 2021;42:770-2. [PMID: 33557987 DOI: 10.1017/ice.2021.61] [Reference Citation Analysis]